NJ Balanced Advantage Fund
The manager has aggressively tilted toward pharmaceuticals and consumer staples while maintaining near-full equity exposure, signaling conviction in defensive growth amid market volatility. The 17 simultaneous additions and exits, coupled with reduced banking and receivables positions, suggest a tactical rotation away from cyclical exposure toward healthcare and FMCG resilience. This shift contradicts the fund's "balanced advantage" mandate, revealing a structurally bullish but quality-focused stance rather than dynamic rebalancing.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹14.1800 | — | — | — | — |
| Regular Growth | ₹13.3700 | +1.60% | -0.59% | +9.58% | — |
| Direct IDCW | ₹14.1800 | — | — | — | — |
| Regular IDCW | ₹13.3700 | — | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Torrent Pharmaceuticals Limited | 2.38% |
| Alkem Laboratories Limited | 2.33% |
| Colgate Palmolive (India) Limited | 1.13% |
| Emami Limited | 1.10% |
| Havells India Limited | 1.04% |
| Indiamart Intermesh Limited | 1.03% |
| JB Chemicals & Pharmaceuticals Limited | 0.89% |
| ABB India Limited | 0.58% |
| Max Healthcare Institute Limited | 0.01% |
| GMR Airports Limited | 0.01% |
| Apollo Hospitals Enterprise Limited | 0.01% |
| One 97 Communications Limited | 0.00% |
| Grasim Industries Limited | 0.00% |
| 91 Days Tbill (MD 30/07/2026) | 0.20% |
| 182 Days Tbill (MD 17/07/2026) | 0.14% |
| 364 Days Tbill (MD 23/07/2026) | 0.14% |
| 364 Days Tbill (MD 03/12/2026) | 0.07% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | HDFC Bank Limited INE040A01034 | 6.22% |
| 2 | Clearing Corporation of India Ltd nan | 5.36% |
| 3 | Reliance Industries Limited INE002A01018 | 4.33% |
| 4 | Eicher Motors Limited INE066A01021 | 3.48% |
| 5 | Marico Limited INE196A01026 | 3.24% |
| 6 | Britannia Industries Limited INE216A01030 | 3.22% |
| 7 | ICICI Bank Limited INE090A01021 | 3.20% |
| 8 | Bosch Limited INE323A01026 | 2.98% |
| 9 | ITC Limited INE154A01025 | 2.84% |
| 10 | Oil & Natural Gas Corporation Limited INE213A01029 | 2.70% |
| 11 | Sun Pharmaceutical Industries Limited INE044A01036 | 2.48% |
| 12 | Cipla Limited INE059A01026 | 2.46% |
| 13 | Dr. Reddy's Laboratories Limited INE089A01031 | 2.45% |
| 14 | Torrent Pharmaceuticals Limited INE685A01028 | 2.38% |
| 15 | Alkem Laboratories Limited INE540L01014 | 2.33% |
| 16 | HDFC Asset Management Company Limited INE127D01025 | 2.30% |
| 17 | Dr. Lal Path Labs Limited INE600L01024 | 2.30% |
| 18 | Nestle India Limited INE239A01024 | 2.16% |
| 19 | Kotak Mahindra Bank Limited INE237A01036 | 2.07% |
| 20 | Pidilite Industries Limited INE318A01026 | 1.68% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does NJ Balanced Advantage Fund hold?
NJ Balanced Advantage Fund holds 141 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 22.63% of NAV.
What is the largest holding in NJ Balanced Advantage Fund?
The largest position in NJ Balanced Advantage Fund is HDFC Bank Limited, accounting for 6.22% of NAV in the Banks sector.
Is NJ Balanced Advantage Fund a concentrated or diversified fund?
With a Gini coefficient of 0.679, NJ Balanced Advantage Fund is highly concentrated. The HHI concentration index is 23,755 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 22.63% of the portfolio.
What is the market cap allocation of NJ Balanced Advantage Fund?
Based on SEBI's AMFI classification, NJ Balanced Advantage Fund's equity portfolio is split as: Large Cap: 59.40%, Mid Cap: 15.06%, Small Cap: 13.48%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does NJ Balanced Advantage Fund invest in most?
NJ Balanced Advantage Fund has the highest allocation to Pharmaceuticals & Biotechnology (14.55%), Banks (13.37%), Automobiles (6.42%). The fund is invested across 38 sectors in total.
How actively managed is NJ Balanced Advantage Fund compared to other Dynamic Asset Allocation Fund funds?
NJ Balanced Advantage Fund has an Active Share of 70.20%, classifying it as "Highly Differentiated" among 35 Dynamic Asset Allocation Fund peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in NJ Balanced Advantage Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, NJ Balanced Advantage Fund added 17 new stocks (including Torrent Pharmaceuticals Limited) and exited 17 stocks (including Bayer Cropscience Limited). Total holding count increased from 140 to 142 stocks.